Cashu | News | GALT

HomeWatchlistNewsSignalsPicks

DJI

+1.19%

SPX

+1.11%

IXIC

+1.43%

FTSE

-0.03%

N225

+0.39%

AXJO

+0.04%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Galectin Therapeutics News

12 Health Care Stocks Moving In Friday's Intraday Session

finance.yahoo.com

Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer

Feature Image for interests on Chief Executive Officer, Chief Medical Officer, Clinical Trial, Development Program from finance.yahoo.com

finance.yahoo.com

Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

Feature Image for interests on Advanced, Clinical Trial, Healthcare, Melanoma from finance.yahoo.com

finance.yahoo.com

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress

Feature Image for interests on Chronic Liver Disease, Development, Disease Progression, Drug Development from finance.yahoo.com

about 1 year ago

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress

about 1 year ago

finance.yahoo.com

Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update

Feature Image for interests on Galectin Therapeutics, Healthcare, Stock, The Company from finance.yahoo.com

about 1 year ago

Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference

about 1 year ago

finance.yahoo.com

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Feature Image for interests on Drug Targeting, Fda, Healthcare, Madrigal from finance.yahoo.com

over 1 year ago

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

over 1 year ago

finance.yahoo.com

Galectin Therapeutics Inc (GALT) Reports Increased Net Loss in Q3 2023

Feature Image for interests on Galectin Therapeutics Inc, Healthcare, Research And Development, Stock from finance.yahoo.com

over 1 year ago

Stocks

Health Care

galt

Galectin Therapeutics

GALT

-0.07 (-2.82%)

2.41

USD

At close at Jun 24, 20:39 UTC

Latest Cashu News

It seems there's no content provided for me to summarize. Please share the content you'd like summarized regarding Galectin Therapeutics.

It seems you didn't provide the content to summarize. Please share the relevant text about Galectin Therapeutics, and I'll help you create a title!